drugset / Trial / NCT04751084
Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
RandomizedParallel-groupTriple-blindPrevention
Summary
To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.
Timeline
- Start
- 2020-05-30
- Primary completion
- 2024-04-30
- Completion
- 2024-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyoscine butylbromide | Unknown | 20 mg | Intravenous |
Indications
No indication recorded.